Publication: The impact of Thai multidisciplinary smoking cessation program on clinical outcomes: A multicentre prospective observational study
0
0
Issued Date
2022
Resource Type
Language
eng
File Type
application/pdf
ISSN
22962565
Rights Holder(s)
Scopus
Bibliographic Citation
Pediatrics and Neonatology. Vol 63, No.5 (2022), p.489-495
Suggested Citation
Chaisai C., Thavorn K., Wattanasirichaigoon S., Rungruanghiranya S., Thongphiew A., Dilokthornsakul P., Lee S.W.H., Chaiyakunapruk N. The impact of Thai multidisciplinary smoking cessation program on clinical outcomes: A multicentre prospective observational study. Pediatrics and Neonatology. Vol 63, No.5 (2022), p.489-495. doi:10.3389/fpubh.2022.965020 Retrieved from: https://hdl.handle.net/20.500.14740/10048
Abstract
Introduction: Tobacco use is the leading preventable cause of morbidity and mortality worldwide. Since 2010, Thailand has implemented a multidisciplinary smoking cessation clinic, which provides smoking cessation services, but the effectiveness of the clinics was not formally evaluated. This study was conducted to assess the real-world effectiveness of this multidisciplinary smoking cessation program. Methods: We conducted a prospective, multicentre, observational study on Thai participants aged 13 years and older in 24 smoking cessation clinics across Thailand's 13 health regions. Each clinic offered smoking cessation interventions according to the well-established 5As model for smoking cessation (Ask, Advise, Assess, Assist, and Arrange). Outcomes of interest were continuous abstinence rates (CAR) at 3 and 6 months. Biochemical confirmation and self-reporting were used to assess the outcomes. Descriptive statistics (mean, SD, median, IQR, and percentage) were used to analyze the smoking cessation outcomes in both intention-to-treat and per-protocol analysis approaches. Results: Smokers receiving services from the Thai multidisciplinary smoking cessation clinics had CAR of 17.49 and 8.33% at 3 and 6 months, respectively. For those with cardiovascular disease (CVD) or cerebrovascular disease, CAR was found to be 26.36% at 3 months and 13.81% at 6 months. While participants with chronic obstructive pulmonary disease (COPD) had CAR ranging from 32.69% at 3 months to 17.31% at 6 months. Conclusion: The multidisciplinary team smoking cessation clinic was effective in assisting smokers in quitting smoking. The effectiveness of the clinic was more pronounced for smokers with CVD, cerebrovascular disease, or COPD. Findings from this study support a decision to include multidisciplinary smoking cessation clinics in the universal health care benefits package. Copyright © 2022 Chaisai, Thavorn, Wattanasirichaigoon, Rungruanghiranya, Thongphiew, Dilokthornsakul, Lee and Chaiyakunapruk.